The SNAP trial includes all age groups because people of all ages, from newborn babies to the elderly, suffer from Staph aureus bloodstream infections, and the treatments are usually the same. This trial will work out how best to treat people of all ages with Staph aureus bloodstream infections.
Prof Steven Tong presented the SNAP Trial as part of the Australian Clinical Trials Alliance's (ACTA) series of resources related to simplified consent in comparative effectiveness trials.
The SNAP Trial includes consumer representation on the global trial steering committee. Read our consumer representative's experience of being hospitalised with S. Aureus bacteraemia.